COVID-19 (SARS-COV-2): A Potential Cure

We are very proud to announce that Phoenix Biotechnology, Inc. recently secured issuance of patent No. US 10729735 (Method and Composition for Treating Coronavirus Infection). Innovar, L.L.C. is a patent and pharmaceutical technology services provider.